English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90074/105197 (86%)
Visitors : 7156192      Online Users : 36
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/8426


    Title: IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via G alpha q interaction and protein kinase C-alpha/CaMKII activation in H9c2 cardiomyoblast cells
    Authors: Chu, CH (Chu, Chun-Hsien);Tzang, BS (Tzang, Bor-Show);Chen, LM (Chen, Li-Mien);Kuo, CH (Kuo, Chia-Hua);Cheng, YC (Cheng, Yi-Chang);Chen, LY (Chen, Ling-Yun);Tsai, FJ (Tsai, Fuu-Jen);Tsai, CH (Tsai, Chang-Hai);Kuo, WW (Kuo, Wei-Wen);Huang, CY (Huang, Chih-Yang)
    Contributors: 保健系
    Keywords: GROWTH-FACTOR-II;HEART-FAILURE;CARDIAC-HYPERTROPHY;MANNOSE 6-PHOSPHATE;BINDING-PROTEINS;PATHWAYS;CARDIOMYOCYTES;STIMULATION;CALCINEURIN;HORMONE
    Date: 2008-05
    Issue Date: 2010-03-26 10:46:37 (UTC+8)
    Publisher: Asia University
    Abstract: The role played by IGF-II in signal transduction through the IGF-II/mannose-6-phosphate receptor (IGF2R) in heart tissue has been poorly understood. In our previous studies, we detected an increased expression of IGF-II and IGF2K in cardiomyocytes that had undergone pathological hypertrophy. We hypothesized that after binding with IGF-II, IGF2K may trigger intracellular signaling cascades involved in the progression of pathologically cardiac hypertrophy. In this study, we used immunohistochemical analysis of the human cardiovascular tissue array to detect expression of IGF2K. In Our study of H9c2 cardiomyoblast cell cultures, we used the rhodamine phalloidin staining, to measure the cell hypertrophy and western blot to measure the expression of cardiac hypertrophy markets atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in cells treated with IGF-II. We found that a significant association between IMP, overexpression and myocardial infarction. The treatment of H9c2 cardiomyoblast cells with IGF-II not only induced cell hypertrophy but also increased the protein level of ANP and BNP. Using Leu27IGF-II, an analog of IGF-II which interacts selectively with the IGF2R to specifically activate IGF2R signaling cascades, we found that binding of Leu271GF-II to IGF2R), led to all increase in the phosphorylation of protein Kinase C (PKC)-alpha and calcium/calmodulin-dependent protein kinase II (CaMKII) in a G alpha q-dependent manner. By the inhibition of PKC-alpha/CaMKII activity, we found that IGF-II and Leu271GF-II-induced cell hypertrophy and upregulation of ANP and BNP were significantly suppressed. Taken together, this study provides a new insight into the effects of the IGF2R and its downstream signaling in cardiac hypertrophy. The suppression of IGF2R signaling pathways may be a good strategy to prevent the progression of pathological hypertrophy.
    Relation: JOURNAL OF ENDOCRINOLOGY 197 (2): 381-390
    Appears in Collections:[食品營養與保健生技學系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    343.docx0KbUnknown261View/Open
    343.doc38KbMicrosoft Word355View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback